ScandiDos said today that it received the first order for its Delta4 Discover radiation dose verification system in the U.S.
The instrument enables clinics to monitor radiation dosing while patients are receiving treatments, boosting the therapy’s quality and the patient’s safety.
“We serve our community and safety is not just a promise, it is a priority. We look forward to informing our community that our continuing efforts to ensure safe radiation treatments have reached a new pinnacle with our investment and adoption of Discover technology,” Sharon Shoulders, cancer center director at The University Medical Center, said in prepared remarks.
“We are excited about the Discover technology, as it eliminates the guessing game and assumptions about daily dose delivery,” the center’s director of medical physics consultant, Dr. Dharanipathy Rangaraj, added. “This fundamentally changes how we perform quality assurance and document doses delivered to patients using direct measurement.”
“Now, we can determine daily dose variation through measurement, which was never possible before. We believe this new data, including machine dose fluctuation and daily patient anatomy variance, will allow us to study radiobiological effects of daily dose variances on tumors and open a new area of research and new level of assurance,” radiation oncologist Dr. Ramzi Abdulrahman said.
